Immunologic manipulation in AML: From bench to bedside

Leukemia

Volumn 16, Issue 4, 2002, Pages 736-737

  Cooper, M A ^a   Caligiuri, M A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; INTERLEUKIN 2; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; TARGET CELL;

EID: 0036233798     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402411     Document Type: Article

References (16)

1. Biology and clinical relevance of human natural killer cells
2. The biology of human natural killer-cell subsets
3. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
4. Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems
5. Interleukin 15: Biology and relevance to human disease
6. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells
7. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15
8. Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo
9. Prolonged administration of low-dose interleukin-2 (IL-2) to patients (PTS) with acute myeloid leukemia (AML) in remission (CR) expands natural killer (NK) cells without significant clinical toxicity
10. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
11. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors
12. Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset
13. On guard - Activating NK cell receptors
14. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
15. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells
16. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of non-epithelial origin